BNP Paribas Financial Markets
ANTH

BNP Paribas Financial Markets’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

BNP Paribas Financial Markets’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-6
Closed -$2 – 4523
2018
Q1 		$2 Hold
6
– – ﹤0.01% 4219
2017
Q4 		$10 Hold
6
– – ﹤0.01% 4199
2017
Q3 		$9 Hold
6
– – ﹤0.01% 4213
2017
Q2 		$10 Sell
6
-2
-25% -$4 ﹤0.01% 4232
2017
Q1 		$26 Sell
8
-53
-87% -$251 ﹤0.01% 4043
2016
Q4 		$318 Sell
61
-269
-82% -$4.66K ﹤0.01% 4083
2016
Q3 		$8.31K Buy
330
+140
+74% +$3.53K ﹤0.01% 3261
2016
Q2 		$4.7K Buy
+190
New +$5.37K ﹤0.01% 3295
2016
Q1 		– Sell
-1,007
Closed -$37.4K – 3375
2015
Q4 		$37.4K Sell
1,007
-28
-3% -$1.24K ﹤0.01% 3003
2015
Q3 		$50.4K Buy
1,035
+662
+177% +$46.3K ﹤0.01% 2860
2015
Q2 		$25.7K Buy
+373
New +$17.3K ﹤0.01% 2888
2014
Q3 		– Sell
-28
Closed -$753 – 4391
2014
Q2 		$753 Hold
28
– – ﹤0.01% 3510
2014
Q1 		$628 Hold
28
– – ﹤0.01% 2988
2013
Q4 		$682 Buy
+28
New +$722 ﹤0.01% 3899

Other funds holding ANTH

WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

BNP Paribas Financial Markets's ANTH Position: Q2 2018 in Review

BNP Paribas Financial Markets sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2018, closing a stake of 6 shares — an estimated $2 sold.

BNP Paribas Financial Markets first reported a position in ANTH in Q4 2013 and held it in 14 quarters. The position peaked at $50.4K in Q3 2015. 5 funds tracked by Wall St. Rank hold ANTH as of Q2 2018.

  • BNP Paribas Financial Markets reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 6 Anthera Pharmaceuticals, Inc. shares in Q2 2018, an estimated $2.
  • BNP Paribas Financial Markets first reported a position in Anthera Pharmaceuticals, Inc. in Q4 2013 and held it in 14 quarters.
  • BNP Paribas Financial Markets's Anthera Pharmaceuticals, Inc. position peaked at $50.4K in Q3 2015.
  • 5 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2018.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2018, filed 25 Jul 2018.